Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885280882> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2885280882 endingPage "106" @default.
- W2885280882 startingPage "102" @default.
- W2885280882 abstract "In real‐world settings, not much information is probably available on the treatment efficacy of the combination of glecaprevir and pibrentasvir (G/P) as a salvage therapy in failures of prior direct‐acting antiviral (DAA) regimens. Especially, the evolution of NS5A resistance‐associated variants (RAVs) and treatment efficacy in patients who received G/P for failures of prior treatment more than once is unknown. Twenty patients, who were exposed to glecaprevir 300 mg/d and pibrentasvir 120 mg/d for 12 weeks in failures of prior DAAs regimens were evaluated for sustained virological response at 12 weeks after the end of treatment (SVR12). The overall rate of SVR12 was 100%, based on intention‐to‐treat analysis. Five patients infected with genotype 1b, who received G/P for failures of prior treatment more than once, were analyzed for the evolution of RAVs in NS5A region. All of the five patients exhibited SVR12, regardless of the numbers of times of prior treatment (more than once), prior treatment response (nonresponse), and fibrosis stage (FIB‐4 index ≥ 3.25). At the commencement of G/P, all five patients were detected with NS5A RAVs at the position of aa 93. Four patients, except for one, were detected with RAVs at both positions of aa 31 and aa 93 (double mutation). All patients could achieve SVR12 with G/P, regardless of the emergence of NS5A RAVs, accompanied by failure to prior NS5A regimens more than once. In conclusion, our study indicated that G/P was a potentially useful salvage treatment for patients who failed prior DAAs regimens more than once." @default.
- W2885280882 created "2018-08-22" @default.
- W2885280882 creator A5010056452 @default.
- W2885280882 creator A5014470642 @default.
- W2885280882 creator A5015577892 @default.
- W2885280882 creator A5024325916 @default.
- W2885280882 creator A5026182073 @default.
- W2885280882 creator A5031710130 @default.
- W2885280882 creator A5044932403 @default.
- W2885280882 creator A5053329267 @default.
- W2885280882 creator A5057057637 @default.
- W2885280882 creator A5066429603 @default.
- W2885280882 creator A5071497400 @default.
- W2885280882 creator A5084522512 @default.
- W2885280882 creator A5089243471 @default.
- W2885280882 date "2018-09-03" @default.
- W2885280882 modified "2023-10-15" @default.
- W2885280882 title "Favorable efficacy of glecaprevir plus pibrentasvir as salvage therapy for HCV failures to prior direct‐acting antivirals regimens" @default.
- W2885280882 cites W1971792395 @default.
- W2885280882 cites W2040361953 @default.
- W2885280882 cites W2047911275 @default.
- W2885280882 cites W2064387090 @default.
- W2885280882 cites W2106172816 @default.
- W2885280882 cites W2112024536 @default.
- W2885280882 cites W2318156787 @default.
- W2885280882 cites W2342648336 @default.
- W2885280882 cites W2463921556 @default.
- W2885280882 cites W2572157951 @default.
- W2885280882 cites W2667085915 @default.
- W2885280882 cites W2746084941 @default.
- W2885280882 cites W2751450406 @default.
- W2885280882 cites W2759486647 @default.
- W2885280882 cites W2766054212 @default.
- W2885280882 cites W2768486652 @default.
- W2885280882 cites W2790565500 @default.
- W2885280882 doi "https://doi.org/10.1002/jmv.25278" @default.
- W2885280882 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30091810" @default.
- W2885280882 hasPublicationYear "2018" @default.
- W2885280882 type Work @default.
- W2885280882 sameAs 2885280882 @default.
- W2885280882 citedByCount "15" @default.
- W2885280882 countsByYear W28852808822018 @default.
- W2885280882 countsByYear W28852808822019 @default.
- W2885280882 countsByYear W28852808822020 @default.
- W2885280882 countsByYear W28852808822023 @default.
- W2885280882 crossrefType "journal-article" @default.
- W2885280882 hasAuthorship W2885280882A5010056452 @default.
- W2885280882 hasAuthorship W2885280882A5014470642 @default.
- W2885280882 hasAuthorship W2885280882A5015577892 @default.
- W2885280882 hasAuthorship W2885280882A5024325916 @default.
- W2885280882 hasAuthorship W2885280882A5026182073 @default.
- W2885280882 hasAuthorship W2885280882A5031710130 @default.
- W2885280882 hasAuthorship W2885280882A5044932403 @default.
- W2885280882 hasAuthorship W2885280882A5053329267 @default.
- W2885280882 hasAuthorship W2885280882A5057057637 @default.
- W2885280882 hasAuthorship W2885280882A5066429603 @default.
- W2885280882 hasAuthorship W2885280882A5071497400 @default.
- W2885280882 hasAuthorship W2885280882A5084522512 @default.
- W2885280882 hasAuthorship W2885280882A5089243471 @default.
- W2885280882 hasBestOaLocation W28852808821 @default.
- W2885280882 hasConcept C126322002 @default.
- W2885280882 hasConcept C159047783 @default.
- W2885280882 hasConcept C2522874641 @default.
- W2885280882 hasConcept C2776408679 @default.
- W2885280882 hasConcept C2776694085 @default.
- W2885280882 hasConcept C2777103181 @default.
- W2885280882 hasConcept C2780775027 @default.
- W2885280882 hasConcept C2781463415 @default.
- W2885280882 hasConcept C71924100 @default.
- W2885280882 hasConceptScore W2885280882C126322002 @default.
- W2885280882 hasConceptScore W2885280882C159047783 @default.
- W2885280882 hasConceptScore W2885280882C2522874641 @default.
- W2885280882 hasConceptScore W2885280882C2776408679 @default.
- W2885280882 hasConceptScore W2885280882C2776694085 @default.
- W2885280882 hasConceptScore W2885280882C2777103181 @default.
- W2885280882 hasConceptScore W2885280882C2780775027 @default.
- W2885280882 hasConceptScore W2885280882C2781463415 @default.
- W2885280882 hasConceptScore W2885280882C71924100 @default.
- W2885280882 hasFunder F4320311405 @default.
- W2885280882 hasIssue "1" @default.
- W2885280882 hasLocation W28852808821 @default.
- W2885280882 hasOpenAccess W2885280882 @default.
- W2885280882 hasPrimaryLocation W28852808821 @default.
- W2885280882 hasRelatedWork W1995515455 @default.
- W2885280882 hasRelatedWork W2528949658 @default.
- W2885280882 hasRelatedWork W2748952813 @default.
- W2885280882 hasRelatedWork W2885280882 @default.
- W2885280882 hasRelatedWork W2899084033 @default.
- W2885280882 hasRelatedWork W2982696294 @default.
- W2885280882 hasRelatedWork W3006621163 @default.
- W2885280882 hasRelatedWork W3031052312 @default.
- W2885280882 hasRelatedWork W3032375762 @default.
- W2885280882 hasRelatedWork W4386469107 @default.
- W2885280882 hasVolume "91" @default.
- W2885280882 isParatext "false" @default.
- W2885280882 isRetracted "false" @default.
- W2885280882 magId "2885280882" @default.
- W2885280882 workType "article" @default.